Exascale Labs Holdings Inc. (XLAB) Balance Sheet
XLAB balance sheet, FY2025
June 30, 2025 · U.S. dollars$7.3M assets = $20.3M liabilities + −$13.0M equity
Liabilities exceed assets: shareholders’ equity is negative (−$13.0M).
Both columns are drawn to the same scale: what XLAB owns equals what it owes plus shareholders’ equity. Hover a block for its value.
XLAB financial health
Descriptive bands, not a rating. Fiscal FY2025.
XLAB balance sheet trends, FY2024–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $4.4MFY2024 | $7.3MFY2025 | +66.7%/yr | |
| Total liabilities | $9.9MFY2024 | $20.3MFY2025 | +105.6%/yr | |
| Shareholders’ equity | −$5.5MFY2024 | −$13.0MFY2025 | — | |
| Cash & short-term investments | $969,626FY2024 | $4.2MFY2025 | +336.4%/yr | |
| Working capital | −$5.5MFY2024 | −$13.0MFY2025 | −$7.5M | |
| Book value per share | −$0.09FY2024 | −$0.21FY2025 | — | |
| Current ratio | 0.44FY2024 | 0.36FY2025 | −0.08 | |
| Shares outstanding | 63.2MFY2024 | 63.2MFY2025 | 0.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
XLAB assets
XLAB liabilities and equity
XLAB debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
XLAB balance sheet
| FY2025 | FY2024 | |
|---|---|---|
| Assets | ||
| Cash & short-term investments | $4.2M | $969,626 |
| Cash & equivalents | $4.2M | $969,626 |
| Receivables | $152,536 | $123,332 |
| Inventory | $0 | $0 |
| Other current assets | $2.9M | $3.3M |
| Total current assets | $7.3M | $4.4M |
| Property, plant & equipment (net) | $19,600 | $23,696 |
| Goodwill & intangible assets | $0 | $0 |
| Long-term investments | $0 | $0 |
| Other non-current assets | $0 | $0 |
| Total assets | $7.3M | $4.4M |
| Liabilities | ||
| Accounts payable | $90,015 | $128,040 |
| Total current liabilities | $20.3M | $9.9M |
| Long-term debt | $0 | $0 |
| Other long-term liabilities | $0 | $0 |
| Total liabilities | $20.3M | $9.9M |
| Shareholders' equity | ||
| Retained earnings (deficit) | −$13.2M | −$5.6M |
| Total shareholders' equity | −$13.0M | −$5.5M |
| Key figures | ||
| Working capital | −$13.0M | −$5.5M |
| Tangible book value | −$13.0M | −$5.5M |
| Book value per share | −$0.21 | −$0.09 |
| Shares outstanding | 63.2M | 63.2M |
| Current ratio | 0.36 | 0.44 |
| Quick ratio | 0.22 | 0.11 |
| Equity / assets | −177.5% | −125.0% |
| Mar '26 | Dec '25 | Jun '25 | |
|---|---|---|---|
| Assets | |||
| Cash & short-term investments | $984,830 | $996,908 | $4.2M |
| Cash & equivalents | $984,830 | $996,908 | $4.2M |
| Receivables | $1.8M | $1.1M | $152,536 |
| Inventory | $0 | $0 | $0 |
| Other current assets | $5.3M | $4.3M | $2.9M |
| Total current assets | $8.1M | $6.4M | $7.3M |
| Property, plant & equipment (net) | $14,406 | $15,971 | $19,600 |
| Goodwill & intangible assets | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 |
| Other non-current assets | $95,000 | $50,000 | $0 |
| Total assets | $8.2M | $6.5M | $7.3M |
| Liabilities | |||
| Accounts payable | $743,742 | $201,630 | $90,015 |
| Total current liabilities | $29.2M | $24.8M | $20.3M |
| Long-term debt | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 |
| Total liabilities | $29.2M | $24.8M | $20.3M |
| Shareholders' equity | |||
| Retained earnings (deficit) | −$21.1M | −$18.5M | −$13.2M |
| Total shareholders' equity | −$20.9M | −$18.3M | −$13.0M |
| Key figures | |||
| Working capital | −$21.0M | −$18.3M | −$13.0M |
| Tangible book value | −$20.9M | −$18.3M | −$13.0M |
| Book value per share | −$0.33 | −$0.29 | −$0.21 |
| Shares outstanding | 63.2M | 63.2M | 63.2M |
| Current ratio | 0.28 | 0.26 | 0.36 |
| Quick ratio | 0.10 | 0.09 | 0.22 |
| Equity / assets | −253.8% | −281.4% | −177.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.
XLAB financial position
At the end of fiscal 2025 (June 30, 2025), Exascale Labs had total assets of $7.3 million (up 66.7% from a year earlier), total liabilities of $20.3 million and shareholders' equity of -$13.0 million. Its current ratio was 0.36. In the latest quarter (ended March 31, 2026) total assets were $8.2 million and equity -$20.9 million.
Related: XLAB income statement, XLAB cash flow statement, XLAB key metrics. See the XLAB stock overview for the latest quote and news.
XLAB balance sheet FAQ
What are Exascale Labs's total assets?
Exascale Labs reported total assets of $7.3 million at the end of fiscal 2025 (June 30, 2025), compared with $4.4 million a year earlier.
How much cash does Exascale Labs have?
Exascale Labs held $4.2 million in cash and short-term investments at the end of fiscal 2025.
What is Exascale Labs's book value?
Exascale Labs's shareholders' equity (book value) was -$13.0 million at the end of fiscal 2025, or −$0.21 per share.
What is Exascale Labs's current ratio?
Exascale Labs had current assets of $7.3 million and current liabilities of $20.3 million, a current ratio of 0.36 (current liabilities exceed current assets).